Provided by Tiger Fintech (Singapore) Pte. Ltd.

Immunoprecise Antibodies Ltd

0.3849
-0.0201-4.96%
Post-market: 0.3600-0.0249-6.47%19:59 EDT
Volume:1.85M
Turnover:711.10K
Market Cap:17.61M
PE:-0.52
High:0.4050
Open:0.3959
Low:0.3602
Close:0.4050
Loading ...

ImmunoPrecise’s Breakthroughs in Cancer Antibody Therapies

TIPRANKS
·
26 Sep 2024

BRIEF-Immunoprecise Antibodies Advances Therapeutic Innovation With Groundbreaking Rabbit Antibody Developments

Reuters
·
26 Sep 2024

Immunoprecise Antibodies Advances Therapeutic Innovation With Groundbreaking Rabbit Antibody Developments

THOMSON REUTERS
·
26 Sep 2024

ImmunoPrecise Antibodies Advances Therapeutic Innovation with Groundbreaking Rabbit Antibody Developments

Business Wire
·
26 Sep 2024

Press Release: Institute for Portfolio Alternatives Announces 2025 Board of Directors

Dow Jones
·
26 Sep 2024

ImmunoPrecise Sets Virtual Annual General Meeting

TIPRANKS
·
24 Sep 2024

Marcus & Millichap’s IPA Capital Markets Arranges $75 Million Financing for Midtown Manhattan Office-to-Residential Conversion Project

Business Wire
·
20 Sep 2024

ImmunoPrecise Antibodies Price Target Maintained With a $9.00/Share by HC Wainwright & Co.

Dow Jones
·
17 Sep 2024

ImmunoPrecise Achieves AI-Driven Growth Amidst Challenges

TIPRANKS
·
16 Sep 2024

ImmunoPrecise Advances Biotherapeutic Research Efficiency

TIPRANKS
·
16 Sep 2024

ImmunoPrecise Antibodies Q1 2025 GAAP EPS $(0.15) Misses $(0.13) Estimate, Sales $5.300M Miss $6.750M Estimate

Benzinga
·
16 Sep 2024

Immunoprecise Antibodies (Ipa) Reports Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2025

THOMSON REUTERS
·
16 Sep 2024

Immunoprecise Antibodies Q1 Revenue CAD 5.3 Million

THOMSON REUTERS
·
16 Sep 2024

Press Release: ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2025

Dow Jones
·
16 Sep 2024